Science that asks
the hard questions.
A proposed Phase 1/2a study designed to investigate safety and early signals of benefit, with a clear comparison and transparent results.
Explore the researchProudly nonprofit. Purposefully driven.
Recovery deserves more than one way forward. IBOCare Foundation is a nonprofit bringing rigorous ibogaine research and a full year of human support together.
A nonprofit 501(c)(3) foundation for evidence. A future built around people.

Hope starts with
an open path.
Careful research.
Lasting commitment.
Why we exist
People and families need more evidence, more support, and more possibilities.
IBOCare Foundation exists to help advance research into ibogaine for opioid use disorder. Our focus is a carefully designed clinical study that asks important questions—and stays alongside participants long after a treatment session ends.
We believe new possibilities deserve careful investigation, with people’s safety and dignity at the center.
Meet the foundationOur approach
Good intentions are the beginning.
These are the commitments that guide the work.
A proposed Phase 1/2a study designed to investigate safety and early signals of benefit, with a clear comparison and transparent results.
Explore the researchSpecialist screening, monitored clinical admissions and independent oversight are central to the proposed design.
Our safety approachTwelve months of planned follow-up, with daily check-ins and human-led support through SENTINEL.
A year of supportThe research
Could medically supervised ibogaine, combined with sustained recovery support, offer another way forward for people living with opioid use disorder?
That is the question behind our proposed study. It is an investigation—not a promise of a cure.
View the public study record · NCT07871877
Proposed study. Funding and required regulatory and ethics approvals must be in place before treatment begins. Registering interest is not enrollment.
Beyond the treatment room
SENTINEL is the proposed year-long support model: a bridge between clinical care and everyday life.
Explore the participant journeyMedical screening, informed consent and preparation.
Three planned clinical admissions with safety reviews.
Daily check-ins and human-led clinical responses.
Continuing support and follow-up through month 12.
For those who believe in better
Philanthropy can help turn the proposed study into real answers. From specialist clinical monitoring to a year of follow-up, your support can help make careful research possible.
Explore ways to giveOUR ANCHOR PRIORITY
For major gifts and bank transfers, our team will personally guide you through the next steps.
Thoughtful conversations. Shared purpose.The people behind the purpose
Foundation leadership · Lead investigator
Regulatory and FDA/IRB lead in the proposed study team.
Lead investigator
SENTINEL platform and digital data systems.
Proposed physician principal investigator
Owner of Midvalley Family Practice.
Proposed study roles are drawn from the foundation’s donor briefing. Final appointments are subject to confirmation.
Ibogaine is investigational and is not approved by the FDA. The proposed IBOCare study is intended to investigate its safety and early effects under medical supervision. This foundation website does not offer treatment.
You can express interest in future study updates. That is not enrollment or an eligibility decision. Recruitment and treatment depend on funding and the required approvals.
Visit Ways to give to contact the foundation about a gift or bank-transfer instructions. Online payment processing is not currently offered.
The proposed design provides every participant with 12 months of follow-up, including monthly clinic visits, daily check-ins and human-led recovery support.
Hope, with a way forward
Help move careful research and lasting recovery support forward.